---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-007195"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T12:45:54.470315+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Agilon health Q4 net loss $230M, medical margin negative $102M; FY2024 guidance slashed

## Summary
- Q4 revenue $1.06B (+72% YoY) but gross profit of negative $95M vs $16M a year ago.
- Full-year 2023 net loss $263M vs $107M in 2022; Adjusted EBITDA loss $95M.
- Medical margin for Q4 negative $102M; FY2023 $299M vs guidance midpoint $350M.
- FY2024 medical margin guidance cut to $400-450M from prior $560-600M; Adj. EBITDA now loss of $60-15M vs prior profit $40-60M.
- Class of 2025 adds at least 60K MA members across 5 physician groups; entry costs lowered to $55-65M.

## SEC filing metadata
- accession: 0001628280-24-007195
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/0001628280-24-007195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/agl-20240227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-007195
- JSON: https://secwatch.observer/filing/0001628280-24-007195.json
- Plain text: https://secwatch.observer/filing/0001628280-24-007195.txt

## Key facts
- Earnings Releases
  agilon health, inc. reported the three and twelve months ended December 31, 2023 results: revenue Total revenue of $1.06 billion in the fourth quarter 2023 increased 72% compared to $615 million in the fourth quarter 2, net income Net loss of $230 million in the fourth quarter 2023 compared to a loss of $57 million in the fourth quarter 2022. For th. Guidance reaffirmed.
  - Period: the three and twelve months ended December 31, 2023
  - Revenue: Total revenue of $1.06 billion in the fourth quarter 2023 increased 72% compared to $615 million in the fourth quarter 2
  - Net income: Net loss of $230 million in the fourth quarter 2023 compared to a loss of $57 million in the fourth quarter 2022. For th
  - Guidance: reaffirmed
  - Result: reported results
  source text: On February 27, 2024 , agilon health, inc. (“agilon” or the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three and twelve months ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/0001628280-24-007195-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.